Document:

Exhibit 10.1

 

FIFTH AMENDMENT AND WAIVER TO CREDIT AGREEMENT

 

THIS FIFTH AMENDMENT AND WAIVER TO CREDIT AGREEMENT (this “Amendment”), dated as of August 15, 2014 (the “Effective Date”), is entered into by and among VENOCO, INC. (the “Company”) and the undersigned Lenders party to the Credit Agreement defined below, and acknowledged by CITIBANK, N.A., as administrative agent for the Lenders (in such capacity, the “Administrative Agent”).

 

W I T N E S S E T H:

 

WHEREAS, the Company, the Lenders, the Administrative Agent, CITIGROUP GLOBAL MARKETS, INC., as Arranger, THE BANK OF NOVA SCOTIA, as Syndication Agent, KEYBANK NATIONAL ASSOCIATION, as Documentation Agent and the other persons from time to time party thereto have entered into that certain Fifth Amended and Restated Credit Agreement dated as of October 3, 2012 (as amended, supplemented, restated or otherwise modified from time to time, the “Credit Agreement”);

 

WHEREAS, the present Borrowing Base is $280,000,000;

 

WHEREAS, the Company has proposed a Disposition of the Oil and Gas Properties set forth on Annex I attached hereto for a fair cash consideration that will exceed 10% of the present Borrowing Base (the “Proposed Disposition”);

 

WHEREAS, a portion of the Oil and Gas Properties included in the Proposed Disposition have been included in the Borrowing Base;

 

WHEREAS, the Company has requested (i) a waiver of Section 8.2(f) of the Credit Agreement and consent of the undersigned Lenders in order to permit the Proposed Disposition, (ii) the release of the collateral related to the Proposed Disposition and (iii) a reduction of the present Borrowing Base to $180,000,000, as hereinafter provided.

 

NOW THEREFORE, in consideration of the foregoing premises and the mutual agreements set forth herein, the parties hereto agree as follows:

 

SECTION 1.                                                 Definitions.  Unless otherwise defined in this Amendment, each capitalized term used in this Amendment has the meaning assigned to such term in the Credit Agreement.

 

SECTION 2.                                                 Waivers.  To the extent but only to the extent the Proposed Disposition would cause a breach of the following identified provisions of the Credit Agreement, the undersigned Lenders hereby waive as of the Effective Date the prohibition set forth in Section 8.2(f) of the Credit Agreement of a Disposition of Oil and Gas Properties for an aggregate sales price that exceeds 10% of the currently effective Borrowing Base.

 

The express waiver set forth in this Section 2 is limited to the extent described herein and shall not be construed to be a waiver of any of the other terms, provisions, covenants, warranties, Events of Default or agreements contained in the Credit Agreement or in any of the other Loan Documents.  The express waivers set forth in this Section 2 pertain exclusively to the Proposed Disposition and shall not waive any part of Section 8.2 of the Credit Agreement in the event of any other Disposition of assets by the Company.

 

1

 

The Required Lenders also hereby agree to the release of all Liens encumbering the assets subject to the Proposed Disposition on the closing date for the Proposed Disposition and hereby direct the Administrative Agent to execute and deliver to Borrower all documents necessary to release such Liens on the closing date of the Proposed Disposition.

 

SECTION 3.                                                 Conditions and Event of Default.  This Amendment and the waiver granted herein are conditioned upon (i) the Company receiving fair cash consideration for the Proposed Disposition, and (ii) the Company’s making a prepayment of the Loans in the amount of the greater of (a) $185,000,000, or (b) the Net Cash Proceeds received from the Proposed Disposition, such prepayment to be made immediately after the receipt of the cash proceeds of the Proposed Disposition. Failure to meet any of the conditions set forth in this Section 3 shall give rise to an Event of Default of the type described in Section 9.1(e) of the Credit Agreement as if such conditions were a covenant, with the cure periods and remedies related thereto.

 

SECTION 4.                                                 Amendments to the Credit Agreement.  The Credit Agreement is hereby amended as follows:

 

(a)                                 Section 2.6(f) of the Credit Agreement is hereby amended by inserting the following new subclause (v) immediately following the last subclause of such Section 2.6(f):

 

“(v)  The Company shall prepay the Loans immediately upon receipt of any cash proceeds from the Proposed Disposition (as defined in that certain Fifth Amendment and Waiver to Credit Agreement, dated as of August 15, 2014, by and among the Company and the Lenders party thereto and acknowledged by the Administrative Agent).”

 

(b)                                 Section 2.6(c) of the Credit Agreement is hereby amended by inserting the following new language immediately following the last sentence of such Section 2.6(c):

 

“Notwithstanding anything to the contrary in this Agreement, in substitution of the Reserve Report due on or before October 1, 2014, the Company shall deliver the certified Reserve Report described in Section 7.2(c)(ii) on or before September 1, 2014, effective as of July 1, 2014; and upon receipt by the Administrative Agent of such Reserve Report, the Administrative Agent shall make a determination and notify the Lenders of the Semi-Annual Proposed Borrowing Base by October 1, 2014, or if later, within 25 days of the receipt of such Reserve Report; and thereafter the Lenders shall approve or submit their recommendations regarding the Semi-Annual Proposed Borrowing Base in accordance with the terms and conditions of this Section 2.6(c).”

 

SECTION 5.                                                 Representations and Warranties, Etc.  To induce the Administrative Agent and the Lenders to enter into this Amendment, the Company and each of the Loan Parties represents and warrants to the Administrative Agent, the Lenders and the other Persons party to the Credit Agreement that as of the Effective Date:

 

(a)                                 each of the representations and warranties by the Loan Parties contained in the Credit Agreement and in the other Loan Documents are true and correct on and as of the Effective Date in all material respects as though made as of the Effective Date, except those that by their terms relate solely as to an earlier date, in which event they shall be true and correct in all material respects on and as of such earlier date;

 

2

 

(b)                                 the execution, delivery and performance of this Amendment has been duly authorized by all requisite organizational action on the part of the Company and each other Loan Party;

 

(c)                                  the Credit Agreement as modified hereby and each other Loan Document constitute valid and legally binding agreements enforceable against each Loan Party that is a party thereto in accordance with their respective terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent transfer or other similar laws relating to or affecting creditors’ rights generally and by general principles of equity, regardless of whether considered in a proceeding in equity or at law; and

 

(d)                                 no Default or Event of Default exists under the Credit Agreement or any of the other Loan Documents.

 

SECTION 6.                                                 Ratification.  The Company and each other Loan Party hereby ratifies and confirms, as of the Effective Date, (a) the covenants and agreements contained in each Loan Document to which it is a party, including, in each case, as such covenants and agreements may be modified by this Amendment and the transactions contemplated thereby and (b) all of the Obligations under the Credit Agreement and the other Loan Documents.

 

SECTION 7.                                                 Borrowing Base.  The Borrowing Base under the Credit Agreement shall be reduced to $180,000,000 after giving effect to the Proposed Distribution until such time as the Borrowing Base is redetermined in accordance with the Credit Agreement.

 

SECTION 8.                                                 Effectiveness.  This Amendment shall become effective as of the Effective Date when all of the conditions set forth in this Section have been satisfied.

 

(a)                                 The Administrative Agent shall have received executed counterparts of this Amendment from the Company, the Guarantors, and the Required Lenders.

 

(b)                                 The Administrative Agent shall have received all reasonable out-of-pocket fees, costs and expenses incurred in connection with the negotiation, preparation, execution and delivery of this Amendment and related documents (including the fees, charges and disbursements of counsel to the Administrative Agent) for which an invoice has been delivered to the Borrower at least one Business Day prior to the date on which the Required Lenders have executed and delivered this Amendment.

 

SECTION 9.                                                 Governing Law; Severability; Integration.  THIS WAIVER SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK.  If any provision of this Amendment or any other Loan Document is held to be illegal, invalid or unenforceable, (a) the legality, validity and enforceability of the remaining provisions of this Amendment and the other Loan Documents shall not be affected or impaired thereby and (b) the parties shall endeavor in good faith negotiations to replace the illegal, invalid or unenforceable provisions with valid provisions the economic effect of which comes as close as possible to that of the illegal, invalid or unenforceable provisions.  The invalidity of a provision in a particular jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.  This Amendment and the other Loan Documents constitute the entire contract among the parties relating to the subject matter hereof and supersede any and all previous agreements and understandings, oral or written, relating to the subject matter hereof.

 

3

 

SECTION 10.                                          Execution in Counterparts.  This Amendment may be executed by the parties hereto in several counterparts (and by different parties hereto in different counterparts), each of which shall constitute an original and all of which when taken together shall constitute a single document.

 

SECTION 11.                                          Successors and Assigns.  This Amendment shall be binding upon and inure to the benefit of the parties hereto and their respective permitted successors and assigns; provided, however, that (a) the Company may not assign or transfer its rights or obligations hereunder without the prior written consent of the Administrative Agent and each Lender; and (b) the rights of sale, assignment and transfer of the Lenders are subject to Section 11.8 of the Credit Agreement.

 

SECTION 12.                                          Miscellaneous.  (a) On and after the effectiveness of this Amendment, each reference in each Loan Document to “the Credit Agreement”, “thereunder”, “thereof” or words of like import referring to the Credit Agreement shall mean and be a reference to the Credit Agreement as amended, waived or otherwise modified by this Amendment; (b) this Amendment is a Loan Document executed pursuant to the Credit Agreement and shall (unless otherwise expressly indicated therein) be construed, administered and applied in accordance with the terms and provisions of the Credit Agreement; and (c) a facsimile signature of any party hereto shall be deemed to be an original signature for purposes of this Amendment.

 

SECTION 13.                                          ENTIRE AGREEMENT.  THIS AMENDMENT AND THE OTHER LOAN DOCUMENTS REPRESENT THE FINAL AGREEMENT AMONG THE PARTIES AND MAY NOT BE CONTRADICTED BY EVIDENCE OF PRIOR, CONTEMPORANEOUS, OR SUBSEQUENT ORAL AGREEMENTS OF THE PARTIES.  THERE ARE NO UNWRITTEN ORAL AGREEMENTS AMONG THE PARTIES.

 

(Remainder of Page Left Intentionally Blank)

 

4

 

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed as of the date first above written.

 

 

	
 
    	
COMPANY:
    
	
 
    	
 
    
	
 
    	
VENOCO, INC.
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/   Timothy A. Ficker
    
	
 
    	
 
    	
Timothy   A. Ficker, Chief Financial Officer
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
GUARANTORS:
    
	
 
    	
 
    
	
 
    	
WHITTIER PIPELINE CORPORATION
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/   Timothy A. Ficker
    
	
 
    	
 
    	
Timothy   A. Ficker, Chief Financial Officer
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
TEXCAL ENERGY (LP) LLC
    
	
 
    	
By:   
    	
VENOCO, INC.,   its Manager
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/   Timothy A. Ficker
    
	
 
    	
 
    	
Timothy   A. Ficker, Chief Financial Officer
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
TEXCAL ENERGY (GP) LLC
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/   Timothy A. Ficker
    
	
 
    	
 
    	
Timothy   A. Ficker, Chief Financial Officer
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
TEXCAL ENERGY SOUTH TEXAS L.P.
    
	
 
    	
By:   
    	
TEXCAL   ENERGY (GP) LLC,
    
	
 
    	
 
    	
as   general partner
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/   Timothy A. Ficker
    
	
 
    	
 
    	
Timothy   A. Ficker, Chief Financial Officer
    

 

Fifth Amendment and Waiver to Credit Agreement — Signature Page

 

 

AGREED TO AND ACKNOWLEDGED THE FOREGOING:

 

 

	
 
    	
CITIBANK, N.A.,   as Administrative Agent and as a 
    
	
 
    	
Lender
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/   Phil Ballard
    
	
 
    	
 
    	
Phil   Ballard, Managing Director
    

 

 

AGREED TO THE FOREGOING:

 

 

	
 
    	
LENDERS:
    
	
 
    	
 
    
	
 
    	
THE BANK OF NOVA SCOTIA
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/   Terry Donovan
    
	
 
    	
 
    	
Terry   Donovan, Managing Director
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
KEYBANK NATIONAL ASSOCIATION
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/   John Dravenstott
    
	
 
    	
 
    	
John   Dravenstott, Vice President
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
BANK OF AMERICA, N.A.
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/   Raza Jafferi
    
	
 
    	
 
    	
Raza   Jafferi, Vice President
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
RB INTERNATIONAL FINANCE (USA) LLC
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/   Christoph Hoedl
    
	
 
    	
 
    	
Christoph   Hoedl, First Vice President
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/   Steven VanSteenbergen
    
	
 
    	
 
    	
Steven   VanSteenbergen, Vice President
    

 

Fifth Amendment and Waiver to Credit Agreement — Signature Page

 

 

	
 
    	
BOKF, NA dba BANK OF OKLAHOMA
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/   Sonja Borodko
    
	
 
    	
 
    	
Sonja   Borodko, Vice President
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
AMEGY BANK NATIONAL ASSOCIATION
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/   Kevin Donaldson
    
	
 
    	
 
    	
Kevin   Donaldson, SVP
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/   Michael Spaight
    
	
 
    	
 
    	
Michael   Spaight, Authorized Signatory
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/   Samuel Miller
    
	
 
    	
 
    	
Samuel   Miller, Authorized Signatory
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
SANTANDER BANK, N.A.
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/   Aidan Lanigan
    
	
 
    	
 
    	
Aidan   Lanigan, Senior Vice President
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/   Vaughn Buck
    
	
 
    	
 
    	
Vaughn   Buck, Executive Vice President
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
ABN AMRO CAPITAL USA LLC
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/   David Montgomery
    
	
 
    	
 
    	
David   Montgomery, Executive Director
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/   Darrell Holley
    
	
 
    	
 
    	
Darrell   Holley, Managing Director
    

 

Fifth Amendment and Waiver to Credit Agreement — Signature Page

 

 

	
 
    	
CIT FINANCE LLC, as   Lender
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/   John Feeley
    
	
 
    	
 
    	
John   Feeley, Director
    

 

Waiver to Credit Agreement — Annex 1Exhibit 10.11

 

THIRD AMENDMENT TO EVALUATION AND EXCLUSIVE
OPTION AGREEMENT

 

Made and entered in to this 15th day of
August, 2014

 

By and between

 

YEDA RESEARCH AND DEVELOPMENT COMPANY
LIMITED

 

a company duly registered under the
laws of Israel of P O Box 95, Rehovot 76100, Israel

(hereinafter, “Yeda”)

 

and

 

CELL SOURCE LIMITED 

 

a company duly registered under the
laws of Israel of 65 Yigal Alon St., Toyota Tower, 23rd Floor, Tel Aviv 67443, Israel

(hereinafter, “Cell Source”)

 

		WHEREAS	Yeda and Cell Source are parties to an evaluation and exclusive
option agreement dated October 3, 2011 as amended on April 1, 2014 and further amended on June 22, 2014 ("the E&O
Agreement”); and

 

		WHEREAS	the parties are contemplating to enter into a Research and
License Agreement, pursuant to which Yeda shall grant to Cell Source a worldwide exclusive license in respect of, inter alia,
a certain invention, more fully described in PCT patent application no. PCT/IB2012/057042 entitled “MAMMALIAN FETAL PULMONARY
CELLS AND THERAPEUTIC USE OF SAME” (Yeda ref. 2011-092), and any further development arrived at under the Research, as shall
be outlined in the said Agreement, whether covered by this patent or another current or future patent application developed under
the said Research; and

 

		WHEREAS	Cell Source has also requested to preserve its option to
obtain a licence to the Patents and the Inventions under the E&O Agreement (the “Option”) that may be relevant
to Cell Source’s business, and has further requested to extend the Option until December 31, 2015; and

 

		WHEREAS	the parties hereby agree that the said preservation and
extension of the Option shall be subject to the acknowledgements and representations of Cell Source set out herein below,

 

NOW THEREFORE IT IS AGREED BY THE PARTIES
HERETO AS FOLLOWS:

 

		1.	Terms and phrases used in this Amendment which
are defined in the E&O Agreement shall have in this Amendment the same meaning as that attributed to them in the E&O Agreement,
unless otherwise expressly defined in this Amendment. The above preamble forms an integral part of this Amendment.

 

    	 

    	 

    

 

		2.	Cell Source hereby acknowledges and represents that:

 

		2.1	it has been informed by Yeda that certain of the scientists
listed as inventors to the Inventions in the applicable Patents were, during part or all of the period in which they contributed
to such Inventions at the Institute, physicians that may have been affiliated with various respective health care institutions
in Israel other than the Institute (the “Other Institutions” and the “Employed Inventors”,
respectively);

 

		2.2	Yeda intends to investigate the above issue and, if necessary,
to make commercially reasonable efforts to resolve it in a manner that will, de facto, provide Cell Source with the opportunity
to license these Inventions on an exclusive worldwide basis in a manner that will be acceptable to the Other Institutions; and

 

		2.3	in light of the above, Yeda may not have full right and
title to the Patents and the Inventions that are the subject of the Option, and therefore, the Option is limited to the rights
that Yeda shall in fact have in respect of the Patents and the Inventions (as the case may be) at the time of the exercise (if
exercised) of the Option by Cell Source (the “Yeda Rights”) and Cell Source hereby waives any claim against
Yeda in that respect.

 

		3.	Subject to the above, the E&O Agreement shall be modified,
such that, the Option detailed in clause 7.1 thereto shall be limited to the Yeda Rights and the words “until September
1st, 2014” in the said clause shall be replaced by the words “until December 31st, 2015”.

 

		4.	This Amendment and the E&O Agreement shall be read
as one and shall represent the complete current understanding between the parties with respect to the subject matter hereof. Subject
to the modifications contained herein, the provisions of the E&O Agreement shall remain unaltered and in full force and effect.

 

IN WITNESS WHEREOF the parties hereto have
set their signatures as of the date set out above.

 

	for	YEDA RESEARCH AND DEVELOPMENT CO., LTD.	 	for	CELL SOURCE LIMITED
	 	 	 	 	 
	 	 	 	 	 
	Signature:	 	 	Signature:	 
	 	 	 	 	 
	Name:	 	 	Name:	 
	 	 	 	 	 
	Title:	 	 	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00234-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00234-of-00352.parquet"}]]